Brian Lawenda, MD
Radiation Oncology · Venice, FLNPI 1104896794
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Telix Pharmaceuticals at 59.3% of the total. Reporting peaked in 2022 at $4,097 and has fallen 87.3% since, to $522 in 2025.
Across 45 payments — averaging $147.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Telix Pharmaceuticals$4K
- Boston Scientific$1K
- Bayer$252
- Myriad Genetic Laboratories, Inc.$207
- Progenics Pharmaceuticals, Inc.$168
- Hologic Sales And Service, LLC$147
- plus $528 from 10 others
What the payments were for
- Speaking & faculty fees$3,94859%
- Travel & lodging$97415%
- Food & beverage$1,73426%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Telix Pharmaceuticals | 1 | $3,948 |
| Boston Scientific | 13 | $1,406 |
| Bayer | 7 | $252 |
| Myriad Genetic Laboratories, Inc. | 7 | $207 |
| Progenics Pharmaceuticals, Inc. | 3 | $168 |
| Hologic Sales And Service, LLC | 1 | $147 |
| Intuitive Surgical | 1 | $135 |
| Novartis | 1 | $120 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $53 |
| AstraZeneca | 2 | $53 |
| Fortovia Therapeutics, Inc. | 3 | $46 |
| Pfizer | 1 | $31 |
| Teleflex LLC | 1 | $28 |
| Palette Life Sciences, Inc. | 1 | $25 |
| Novocure Inc. | 1 | $20 |
| Myovant Sciences Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,656 in reported general payments places this provider in the 85th percentile of 465 radiation oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin Hcl | 12 | $24 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Venice
- Shravan KandulaOrlando$444K
- Martin KeischMiami Shores$319K
- Marcio FagundesMiami$274K
- Evan ThomasWinter Park$209K
- Rupesh KotechaMiami$208K
- John SylvesterLakewood Ranch$205K
- Ravi ShridharOrlando$192K
- Alan BrownFort Myers$165K
- Akash NandaOrlando$165K
- Michael ChuongMiami$152K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.